Skip to main content
Top
Published in: memo - Magazine of European Medical Oncology 1/2017

01-02-2017 | editorial

To print or not to print

Or the publisher’s dilemma how to present a growing complexity of scientific knowledge to clinicians, helping them to improve their daily care for their patients

Authors: Wolfgang Hilbe, MD, Rupert Bartsch, MD, Waltraud Radlherr

Published in: memo - Magazine of European Medical Oncology | Issue 1/2017

Login to get access

Excerpt

Ten years ago, in spring 2007 a noble lady wearing a queenly looking hat invited me (WH) to start a new printed journal on hematology and oncology with a focus on the German-speaking community. The well-known publisher Springer Company intended to expand in that field of medicine. Certainly, it was a distinguished honor being selected for such a project. But, analyzing the opportunities and potential draw-backs of such a project, I came to the conclusion: “hands off!”. Considering the small number of Austrian hematologists and medical oncologists, the potential of authors or reviewers would have been fully exhausted within the first three issues.
Metadata
Title
To print or not to print
Or the publisher’s dilemma how to present a growing complexity of scientific knowledge to clinicians, helping them to improve their daily care for their patients
Authors
Wolfgang Hilbe, MD
Rupert Bartsch, MD
Waltraud Radlherr
Publication date
01-02-2017
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 1/2017
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0317-5

Other articles of this Issue 1/2017

memo - Magazine of European Medical Oncology 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine